BOOK

FindCenter AddIcon
Book Image

The Dialectical Behavior Therapy Skills Workbook for PTSD: Practical Exercises for Overcoming Trauma and Post-Traumatic Stress Disorder

Book Image

By Kirby Reutter — 2019

This pragmatic workbook offers evidence-based skills grounded in dialectical behavior therapy (DBT) to help you find lasting relief from trauma and post-traumatic stress disorder (PTSD). If you’ve experienced trauma, you should know that there is nothing wrong with you. See more...

FindCenter Video Image
02:04

Higher Dose Ketamine Infusions to Treat PTSD

PTSD can be very challenging to treat.

FindCenter AddIcon
FindCenter Video Image
13:25

Can Ketamine and MDMA Treat Trauma?

This weeks video looks at the effects of MDMA/ecstasy and ketamine as a treatment option for ptsd. The biological mechanisms involved in these drugs for ptsd as well as depression/anxiety are mentioned, as well as the therapeutic benefits and research in the area.

FindCenter AddIcon
FindCenter Video Image
02:17

Repeated Ketamine Infusions Reduce Symptoms in PTSD Patients

Repeated intravenous (IV) ketamine infusions significantly reduce symptom severity in individuals with chronic post-traumatic stress disorder (PTSD) and the improvement is rapid and maintained for several weeks afterwards, according to a study conducted by researchers from the Icahn School of...

FindCenter AddIcon
FindCenter Video Image
01:00:50

Ketamine: Why Now? How? Where Do We Go from Here?

Each month The Brain & Behavior Research Foundation hosts a Meet the Scientist Webinar featuring a researcher discussing the latest findings related to mental illness. In June, 2018, the Foundation featured Dr. John H. Krystal of the Yale University School of Medicine.

FindCenter AddIcon
FindCenter Video Image

Ecstasy as a Remedy for PTSD? You Probably Have Some Questions.

The drug known by the street names Ecstasy or Molly could be a promising treatment for post-traumatic stress disorder, according to a new study.

FindCenter AddIcon
FindCenter Video Image

MDMA Lauded as ‘Breakthrough’ Therapy for PTSD Patients

The Food and Drug Administration (FDA) has approved the design of two Phase 3 clinical trials of MDMA for treating PTSD, according to the Multidisciplinary Association for Psychedelic Studies (MAPS), which is funding and leading the clinical trials.

FindCenter AddIcon

EXPLORE TOPIC

Emotional and Mental Health